Comparative study of the plasma pharmacokinetics and tissue concentrations of danofloxacin and enrofloxacin in broiler chickens
- 1 August 1999
- journal article
- research article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 22 (4), 239-246
- https://doi.org/10.1046/j.1365-2885.1999.00217.x
Abstract
The plasma pharmacokinetics of danofloxacin and enrofloxacin in broiler chickens was investigated following single intravenous (i.v.) or oral administration (p.o.), and the steady‐state plasma and tissue concentrations of both drugs were investigated after continuous administration via the drinking water. The following dosages approved for the treatment of chickens were used: danofloxacin 5 mg/kg and enrofloxacin 10 mg/kg of body weight. Concentrations of danofloxacin and enrofloxacin including its metabolite ciprofloxacin were determined in plasma and eight tissues by specific and sensitive high performance liquid chromatography methods. Pharmacokinetic parameter values for both application routes calculated by noncompartmental methods were similar for danofloxacin compared to enrofloxacin with respect to elimination half‐life (t1/2; ≈ 6–7 h), mean residence time (MRT; 6–9 h) and mean absorption time (MAT; 1.44 vs. 1.20 h). However, values were twofold higher for body clearance (ClB; 24 vs. 10 mL/min. kg) and volume of distribution at steady state (VdSS; 10 vs. 4 L/kg). Maximum plasma concentration (Cmax) after oral administration was 0.5 and 1.9 μg/mL for danofloxacin and enrofloxacin, respectively, occurring at 1.5 h for both drugs. Bioavailability (F) was high: 99% for danofloxacin and 89% for enrofloxacin. Steady‐state plasma concentrations (mean ± SD) following administration via the drinking water were fourfold higher for enrofloxacin (0.52 ± 0.16 μg/mL) compared to danofloxacin (0.12 ± 0.01 μg/mL). The steady‐state AUC0–24h values of 12.48 and 2.88 μg.h/mL, respectively, derived from these plasma concentrations are comparable with corresponding area under the plasma concentration‐time curve (AUC) values after single oral administration. For both drugs, tissue concentrations markedly exceeded plasma concentrations, e.g. in the target lung, tissue concentrations of 0.31 ± 0.07 μg/g for danofloxacin and 0.88 ± 0.24 μg/g for enrofloxacin were detected. Taking into account the similar in vitro activity of danofloxacin and enrofloxacin against important pathogens in chickens, a higher therapeutic efficacy of water medication for enrofloxacin compared to danofloxacin can be expected when given at the approved dosages.Keywords
This publication has 15 references indexed in Scilit:
- Comparison of the Efficacies of Three Fluoroquinolone Antimicrobial Agents, Given as Continuous or Pulsed-Water Medication, against Escherichia coli Infection in ChickensAntimicrobial Agents and Chemotherapy, 1998
- Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolonesAntimicrobial Agents and Chemotherapy, 1997
- In vitro activity of premafloxacin, a new extended-spectrum fluoroquinolone, against pathogens of veterinary importanceAntimicrobial Agents and Chemotherapy, 1997
- Fluoroquinolones in animal healthJournal of Veterinary Pharmacology and Therapeutics, 1996
- In vitro evaluation of various antimicrobials against Mycoplasma gallisepticum and Mycoplasma synoviae by the micro‐broth method, and comparison with a commercially‐prepared test systemAvian Pathology, 1994
- Simultaneous determination of benofloxacin, danofloxacin, enrofloxacin and ofloxacin in chicken tissues by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- Residue depletion studies on danofloxacin in the chickenJournal of Agricultural and Food Chemistry, 1994
- In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importanceResearch in Veterinary Science, 1993
- Pharmacodynamics of intravenous ciprofloxacin in seriously ill patientsAntimicrobial Agents and Chemotherapy, 1993
- Clinical pharmacokinetics of parenterally administered danofloxacin in cattleJournal of Veterinary Pharmacology and Therapeutics, 1991